Motley Fool Premium
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (TSX: BHC)
    3. /

TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    4 Reasons Valeant Pharmaceuticals Intl Inc. Might Be a Good Investment Today

    | David Jagielski

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is down over 20% in the past month and could present a great buying opportunity.

    Read more »

    The Motley Fool
    Investing

    Better Turnaround Play: Bombardier, Inc. vs. Valeant Pharmaceuticals Intl Inc.

    | Joey Frenette

    Bombardier, Inc. (TSX:BBD.B) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are two popular contrarian picks. Here's which one investors should consider…

    Read more »

    The Motley Fool
    Investing

    3 Reasons You Should Be Wary of Valeant Pharmaceuticals Intl Inc.

    | Ambrose O'Callaghan

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a risky buy during a recovery period and with general headwinds building.

    Read more »

    The Motley Fool
    Investing

    Why an Investment in Valeant Pharmaceuticals Intl Inc. Needs to Be Long Term

    | Chris MacDonald

    Short-term traders should stay away from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), but long-term investors should take a look.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Still a Risk or on the Way up?

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could experience amazing growth, but with all that debt, it remains incredibly risky.

    Read more »

    The Motley Fool
    Investing

    Danger: 3 Types of Stocks to Avoid in a Rising Interest Rate Environment

    | Kay Ng

    Who controls interest rates? And why would it be dangerous to invest in stocks like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX)…

    Read more »

    The Motley Fool
    Investing

    How Rising Rates May Bankrupt Valeant Pharmaceuticals Intl Inc.

    | Ryan Goldsman

    With higher rates leading to higher interest costs, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are on their way down.

    Read more »

    The Motley Fool
    Investing

    Long-Term Investors: Buy the Dip With Valeant Pharmaceuticals Intl Inc.

    | Chris MacDonald

    Where are shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) headed after extreme volatility of late?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical Intl Inc. Is Back on the Growth Track: Time to Buy?

    | Joey Frenette

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) suffered a massive 9.57% plunge following a huge +10% post-earnings rally. Should investors buy as…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc.’s Stock Is Soaring Over 10%

    | David Jagielski

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is up 10%. Should you be buying or selling?

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Dropping Is of Little Consequence

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) dropped nearly 10% in the past week, but the stock is becoming an intriguing turnaround…

    Read more »

    Investing

    Which Should You Buy: Valeant Pharmaceuticals Intl Inc. or Home Capital Group Inc.?

    | David Jagielski

    Home Capital Group Inc. (TSX:HCG) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have seen their stock prices fall this year. Can either…

    Read more »